Buchhave P - Search Results

1

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J. Höglund K, et al. Among authors: buchhave p. Neurodegener Dis. 2008;5(5):268-76. doi: 10.1159/000119457. Epub 2008 Feb 29. Neurodegener Dis. 2008. PMID: 18309230

2

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Hansson O, et al. Among authors: buchhave p. Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19. Dement Geriatr Cogn Disord. 2007. PMID: 17374949

3

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Hansson O, et al. Among authors: buchhave p. Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23. Neurobiol Aging. 2009. PMID: 17646035

4

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.

Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ, Blennow K. Zetterberg H, et al. Among authors: buchhave p. Arch Neurol. 2008 Aug;65(8):1102-7. doi: 10.1001/archneur.65.8.1102. Arch Neurol. 2008. PMID: 18695061

5

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.

Buchhave P, Blennow K, Zetterberg H, Stomrud E, Londos E, Andreasen N, Minthon L, Hansson O. Buchhave P, et al. PLoS One. 2009 Jul 17;4(7):e6294. doi: 10.1371/journal.pone.0006294. PLoS One. 2009. PMID: 19609443 Free PMC article.

6

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Buchhave P, et al. Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155. Arch Gen Psychiatry. 2012. PMID: 22213792

7

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Among authors: buchhave p. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

8

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease.

Buchhave P, Stomrud E, Warkentin S, Blennow K, Minthon L, Hansson O. Buchhave P, et al. Dement Geriatr Cogn Disord. 2008;25(6):544-52. doi: 10.1159/000137379. Epub 2008 Jun 6. Dement Geriatr Cogn Disord. 2008. PMID: 18535375

9

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

Buchhave P, Janciauskiene S, Zetterberg H, Blennow K, Minthon L, Hansson O. Buchhave P, et al. Neurosci Lett. 2009 Jan 23;450(1):56-9. doi: 10.1016/j.neulet.2008.10.091. Epub 2008 Nov 5. Neurosci Lett. 2009. PMID: 18996438

10

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment.

Buchhave P, Zetterberg H, Blennow K, Minthon L, Janciauskiene S, Hansson O. Buchhave P, et al. Neurobiol Aging. 2010 Nov;31(11):1877-84. doi: 10.1016/j.neurobiolaging.2008.10.012. Epub 2008 Dec 13. Neurobiol Aging. 2010. PMID: 19070941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters